Marvin Gee, PhD
Dr. Gee is responsible for leading target discovery and computation at 3T. He received his PhD in Immunology, with an additional focus in Computational Immunology, at Stanford University with thesis work in the laboratory of K. Christopher Garcia, which formed the basis of 3T Biosciences. He published his main work on novel technology to identify the specificities of T- cell receptors for applications in oncology and further work on characterizing the structural basis of T- cell receptor recognition of immunological targets and T cell receptor cross-reactivity. He has had prior work experience engineering T cell receptors for adoptive T cell therapy. He has been featured in Forbes 30-under-30 in Healthcare.